These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 1099964
1. Activation of the complement and properdin systems in rheumatoid arthritis. Ruddy S, Austen KF. Ann N Y Acad Sci; 1975 Jun 13; 256():96-104. PubMed ID: 1099964 [Abstract] [Full Text] [Related]
2. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis. Perrin LH, Nydegger UE, Zubler RH, Lambert PH, Miescher PA. Arthritis Rheum; 1977 Mar 13; 20(2):647-52. PubMed ID: 849359 [Abstract] [Full Text] [Related]
3. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway. Fearon DT, Austen KF, Ruddy S. Rheumatology; 1975 Mar 13; 6():2-16. PubMed ID: 1105744 [No Abstract] [Full Text] [Related]
4. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. Whaley K, Schur PH, Ruddy S. J Clin Invest; 1976 Jun 13; 57(6):1554-63. PubMed ID: 819459 [Abstract] [Full Text] [Related]
8. Clinical applications of complement measurements in rheumatic diseases. Goldstein IM. Am J Med Sci; 1975 Jul 13; 269(2):172-82. PubMed ID: 1096603 [Abstract] [Full Text] [Related]
9. Activation of complement components C3 and factor B in synovial fluids. Hunder GG, McDuffie FC, Mullen BJ. J Lab Clin Med; 1977 Jan 13; 89(1):160-71. PubMed ID: 830776 [Abstract] [Full Text] [Related]
10. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera. Baatrup G, Jonsson H, Sjöholm A, Sturfelt G, Svehag SE. J Clin Lab Immunol; 1988 Jun 13; 26(2):73-9. PubMed ID: 3264027 [Abstract] [Full Text] [Related]
11. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum. Machado AJ, Gazzinelli G, Pellegrino J, Dias de Silva W. Exp Parasitol; 1975 Aug 13; 38(1):20-9. PubMed ID: 807484 [No Abstract] [Full Text] [Related]
12. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN). Geiger H, Good RA, Day NK. Clin Nephrol; 1975 Aug 13; 3(4):139-47. PubMed ID: 1149337 [Abstract] [Full Text] [Related]
13. Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis. de Ceulaer C, Papazoglou S, Whaley K. Immunology; 1980 Sep 13; 41(1):37-43. PubMed ID: 6903558 [Abstract] [Full Text] [Related]
14. Activation of the complement system by antibody-antigen complexes: the classical pathway. Porter RR, Reid KB. Adv Protein Chem; 1979 Sep 13; 33():1-71. PubMed ID: 396780 [No Abstract] [Full Text] [Related]
15. Altered local metabolism of complement components in rheumatoid arthritis. Ruddy S. Rheumatology; 1975 Sep 13; 6():17-23. PubMed ID: 1105743 [No Abstract] [Full Text] [Related]
16. The proteolytic activation systems of complement. Reid KB, Porter RR. Annu Rev Biochem; 1981 Sep 13; 50():433-64. PubMed ID: 7023363 [No Abstract] [Full Text] [Related]
18. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. Medicus RG, Götze O, Müller-Eberhard HJ. J Exp Med; 1976 Oct 01; 144(4):1076-93. PubMed ID: 978134 [Abstract] [Full Text] [Related]
20. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Des Prez RM, Bryan CS, Hawiger J, Colley DG. Infect Immun; 1975 Jun 01; 11(6):1235-43. PubMed ID: 806523 [Abstract] [Full Text] [Related] Page: [Next] [New Search]